NEW YORK – GenMark Diagnostics reported after the close of the market on Monday that its fourth quarter revenues rose 40 percent year over year, in line with preliminary Q4 revenues reported in January.
For the three months ended Dec. 31, 2019, the company reported revenues of $27.2 million, up from $19.4 million in Q4 2018 but missing analysts' consensus estimate of $27.4 million.